Abstract 1388 My Journey to Drug Discovery in Ovarian Cancer
time and cost of identifying initial hit molecules for DOR-KOR protomers for testing in novel targets like the DOR-KOR heteromer.Given the dire need for effective pain treatment for persistent neuropathic pain conditions, the path to developing safer opioid alternatives is promising.
Authors
- A. Douglas Kinghorn (ORCID: https://orcid.org/0000-0002-6647-8707)
- Elizabeth N. Kaweesa (ORCID: https://orcid.org/0000-0002-9799-646X)
- Nicole M. Benson (ORCID: https://orcid.org/0000-0001-5361-4311)
- Joanna E. Burdette (ORCID: https://orcid.org/0000-0002-7271-6847)
- Jaqueline Moraes Bazioli (ORCID: https://orcid.org/0000-0001-8219-8759)
- James R. Fuchs (ORCID: https://orcid.org/0000-0002-8743-6389)
- Pan Li (ORCID: https://orcid.org/0000-0002-0316-0355)
- Tyler A. Wilson (ORCID: https://orcid.org/0000-0002-9467-8909)
Institutions
- University of Illinois Chicago (US)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.jbc.2025.109029
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00